Ozempic (semaglutide)

Novo Nordisk

Ozempic (semaglutide) injection is a once-weekly medication in the GLP-1 receptor agonist class of drugs. It is used in adults with type 2 diabetes, along with diet and exercise, to improve glucose. It is also used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease. It helps to release insulin and lowers the amount of glucose produced by the liver when glucose rises at mealtime. It also slows the absorption of mealtime glucose. Ozempic has been approved at a 2-mg dose if additional blood glucose control is needed.



Generic Name:
Drug Class:
GLP-1 receptor agonists
Medication Type: